ID
37361
Descripción
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains the Study Conclusion, information on the treatment blind and whether a pregnancy has occured during the study, as well as the Investigator's Signature. This form is to be completed at Follow-up or if the participant has/was withdrawn from the trial.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Palabras clave
Versiones (1)
- 20/7/19 20/7/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
20 de julio de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Study Conclusion
- StudyEvent: ODM
Descripción
Study Conclusion
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008976
Descripción
Date last contact
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0805839
Descripción
If no: Date of last contact must match the last scheduled study visit date. If yes: complete details. Date of decision to withdraw must match the date of decision to withdraw the subject from the study before normal completion. Date of last contact must match the last actual contact with the subject whether or not the contact was a clinic visit. Do not record dates of unsuccessful attempts to contact the subject. Note: An ’actual contact’ is defined as an interaction between the subject and the investigator or investigator’s designee, where the investigator/designee has the opportunity to query the subject about the subject’s status. This would include clinic visits and telephone contacts, but normally would not include mail correspondence or third party reports.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0422727
Descripción
if applicable
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
- UMLS CUI [1,3]
- C0011008
Descripción
if 1 = Adverse Event, please record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. if 7 = Investigator discretion, specify in next question. Select this reason if none of the other primary reasons are appropriate.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1549995
Descripción
if applicable
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C0008961
- UMLS CUI [1,3]
- C0022423
Descripción
Data owner should check the box when data cleaning is complete
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1706256
- UMLS CUI [1,2]
- C1519316
Descripción
Office Use 1 [hidden]
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0442603
Descripción
Office Use 2 [hidden]
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0442603
Descripción
Status of Treatment Blind
Alias
- UMLS CUI-1
- C2347038
- UMLS CUI-2
- C0449438
Descripción
If yes, complete the Adverse Event form and/or Investigational Product forms as appropriate, and additional questions in this form.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3897431
Descripción
if applicable
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C1264639
Descripción
if applicable If other, please specify
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C3897431
- UMLS CUI [1,2]
- C0566251
Descripción
if applicable
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C3897431
- UMLS CUI [1,3]
- C2348235
Descripción
Pregnancy Information (female)
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Descripción
Pregnancy Information (male)
Alias
- UMLS CUI-1
- C0032961
- UMLS CUI-2
- C1533716
Descripción
If Yes, complete the paper Pregnancy Notification form Check "Not Applicable" if female partner not of childbearing potential or no female partner.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0919624
- UMLS CUI [1,2]
- C0439659
- UMLS CUI [1,3]
- C0347984
- UMLS CUI [1,4]
- C0008976
Descripción
Electronic Signature
Alias
- UMLS CUI-1
- C2346576
Descripción
By my dated signature below, I [investigator first and last name] verify that all case report form pages accurately display the results of the examinations, tests, evaluations and treatments performed on this patient.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826892
Descripción
Pursuant to Section 11.100 of Title 21 of the Code of Federal Regulations, this is to certify that I intend that this electronic signature is to be the legally binding equivalent of my handwritten signature.
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Study Conclusion
- StudyEvent: ODM
C1264639 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1549995 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
C1519316 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C3897431 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C1533716 (UMLS CUI-2)
C1533716 (UMLS CUI-2)
C0439659 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
Sin comentarios